Cancer chemotherapy and biological response modifiers最新文献

筛选
英文 中文
Lymphomas. 淋巴瘤。
Armando Santoro, Luca Castagna, Massimo Magagnoli
{"title":"Lymphomas.","authors":"Armando Santoro, Luca Castagna, Massimo Magagnoli","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"399-428"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24660531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancers of the large bowel and hepatobiliary tract. 大肠癌和肝胆道癌。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21024-3
Weijing Sun, Daniel Haller
{"title":"Cancers of the large bowel and hepatobiliary tract.","authors":"Weijing Sun, Daniel Haller","doi":"10.1016/s0921-4410(03)21024-3","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21024-3","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"509-34"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24660535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain tumors. 脑瘤。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21031-0
Jeanette K Pueschel, Lynn S Ashby, William R Shapiro
{"title":"Brain tumors.","authors":"Jeanette K Pueschel, Lynn S Ashby, William R Shapiro","doi":"10.1016/s0921-4410(03)21031-0","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21031-0","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"655-81"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24660542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Supportive care. 支持性护理。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21033-4
Maurie Markman
{"title":"Supportive care.","authors":"Maurie Markman","doi":"10.1016/s0921-4410(03)21033-4","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21033-4","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"709-16"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24660544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tubulin-targeting agents. Tubulin-targeting代理。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21003-6
William N Hait, Eric Rubin, Susan Goodin
{"title":"Tubulin-targeting agents.","authors":"William N Hait, Eric Rubin, Susan Goodin","doi":"10.1016/s0921-4410(03)21003-6","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21003-6","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"41-67"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24661162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Topoisomerase I interactive agents. 拓扑异构酶I相互作用试剂。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21004-8
P Kellie Turner, Lisa C Iacono, Clinton F Stewart
{"title":"Topoisomerase I interactive agents.","authors":"P Kellie Turner,&nbsp;Lisa C Iacono,&nbsp;Clinton F Stewart","doi":"10.1016/s0921-4410(03)21004-8","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21004-8","url":null,"abstract":"<p><p>Increased insight into the mechanism of interaction of topoisomerase I interactive agents will maximize the therapeutic index and enhance the development of additional agents. Preclinical studies designed to elucidate mechanisms by which the topoisomerase I interactive agents induce cell death will be essential. The role of ABC transporters in resistance to topoisomerase I interactive agents has been recently appreciated and future studies should be directed at circumventing this resistance. The results of preclinical studies must be translated into the design of clinical trials so that these agents can be used rationally. In this regard results of preclinical studies have clearly pointed to the enhanced antitumor activity from protracted dosing of topoisomerase I interactive agents and results of clinical trials are now supporting these preclinical findings. Finally, investigators are trying to understand better the mechanism(s) of the dose-limiting toxicities observed with the currently available topoisomerase I interactive agents in an effort to enable the optimal dosing of these agents. Even though the first priority must be to determine the therapeutic potential of the currently available agents, it is reassuring to know that other topoisomerase I interactive agents are currently under development.</p>","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"69-101"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24661163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 47
Genitourinary malignancies. 泌尿生殖器的恶性肿瘤。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21026-7
M Dror Michaelson, Matthew R Smith
{"title":"Genitourinary malignancies.","authors":"M Dror Michaelson,&nbsp;Matthew R Smith","doi":"10.1016/s0921-4410(03)21026-7","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21026-7","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"547-64"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24660537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Topoisomerase II inhibitors. 拓扑异构酶II抑制剂。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21005-x
Kenneth R Hande
{"title":"Topoisomerase II inhibitors.","authors":"Kenneth R Hande","doi":"10.1016/s0921-4410(03)21005-x","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21005-x","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"103-25"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24661164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
Farnesyltransferase inhibitors. 批抑制剂。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21006-1
Alex A Adjei
{"title":"Farnesyltransferase inhibitors.","authors":"Alex A Adjei","doi":"10.1016/s0921-4410(03)21006-1","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21006-1","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"127-44"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24661165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in endocrine therapy for the treatment and prevention of breast cancer. 内分泌疗法在乳腺癌治疗和预防中的研究进展。
Cancer chemotherapy and biological response modifiers Pub Date : 2003-01-01 DOI: 10.1016/s0921-4410(03)21009-7
William J Gradishar, V Craig Jordan
{"title":"Advances in endocrine therapy for the treatment and prevention of breast cancer.","authors":"William J Gradishar,&nbsp;V Craig Jordan","doi":"10.1016/s0921-4410(03)21009-7","DOIUrl":"https://doi.org/10.1016/s0921-4410(03)21009-7","url":null,"abstract":"","PeriodicalId":72508,"journal":{"name":"Cancer chemotherapy and biological response modifiers","volume":"21 ","pages":"211-22"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24661168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信